Search Results 2761-2770 of 18309 for rheumatoid arthritis
... factor receptor 2 (HER2)-negative, unresectable, locally advanced and unresectable or metastatic breast cancer. Study of Pembrolizumab/Vibostolimab ...
... arthritis, Scaphoid fracture, Distal radius fracture, Scaphoid nonunion. Show more areas of focus for Alexander Y. Shin, M.D.. Research. Publications. See a ...
... factor. Patients with undetectable versus detectable HCV RNA had a survival probability of 80% versus 39% at 1 year and 80% versus 30% at 3 and 5 years (p ...
... rheumatology; ear, nose and throat and head and neck surgery; hematology; oncology; pulmonary medicine; gastroenterology and hepatology; neurology ...
Shapiro told Campanini he was eligible for the first-ever randomized clinical trial exploring the safety of stem cells for arthritis. Despite limited ...
Wrap the severed part in saline-moistened gauze and then place it in a plastic bag. Keep the plastic bag on ice. Time is a limiting factor for replantation, so ...
... factor treatment (e.g., erythropoietin), hormones (e.g., androgens, danazol) ≤ 14 days prior to registration; note: patients who are on ruxolitinib may ...
Visible hematuria in subject's urine sample without known contributing factor. Invisible hematuria (or significant microscopic hematuria; i.e., hematuria of ...
Von Willebrand Factor Antigen Improves Risk Stratification for Patients with a Diagnosis of Resectable Hepatocellular Carcinoma. Ann Surg Oncol. 2024 Oct ...
... factor receptor 2 (FGFR2). Ponatinib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Neratinib +/- ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.